Congress Trades in Quest Diagnostics Incorporated (DGX)
7 members of Congress have disclosed trading DGX.
Total trades
10
Purchases
3
Sales
7
Members
7
Est. volume
$80,000
Last traded
Jul 24, 2025
Want the fundamentals on DGX?
DGX stock analysis →
See Quest Diagnostics Incorporated's price, P/E, ROE and a free return calculator.
7 members of Congress have disclosed trading Quest Diagnostics Incorporated (DGX), with 10 transactions in total — 3 purchases and 7 sales worth an estimated $80,000 at range midpoints, leaning heavily toward selling. The most active DGX trader is Earl Blumenauer (2 disclosures). The most recent disclosed DGX trade was on Jul 24, 2025. See our full DGX fundamentals page for price, valuation and a return calculator.
Every disclosed DGX trade
| Disclosed | Politician | Type | Amount | Traded | |
|---|---|---|---|---|---|
| Aug 11, 2025 | Julia Letlow R | Sale | $1,001 - $15,000 | Jul 24, 2025 | filing ↗ |
| Apr 11, 2025 | Carol Devine Miller R | Sale | $1,001 - $15,000 | Mar 10, 2025 | filing ↗ |
| May 3, 2024 | Earl Blumenauer | Sale | $1,001 - $15,000 | Apr 4, 2024 | filing ↗ |
| Apr 2, 2020 | Earl Blumenauer | Purchase | $1,001 - $15,000 | Mar 2, 2020 | filing ↗ |
| Feb 5, 2020 | Dean Phillips | Purchase | $1,001 - $15,000 | Jan 17, 2020 | filing ↗ |
| Jun 7, 2019 | Dean Phillips | Purchase | $1,001 - $15,000 | May 3, 2019 | filing ↗ |
| Sep 15, 2016 | K. Michael Conaway | Sale | $1,001 - $15,000 | Sep 12, 2016 | filing ↗ |
| Jun 20, 2016 | Lois Frankel D | Sale | $1,001 - $15,000 | Jun 20, 2016 | filing ↗ |
| Nov 6, 2014 | Richard L. Hanna | Sale | $1,001 - $15,000 | Oct 15, 2014 | filing ↗ |
| Jan 9, 2014 | Richard L. Hanna | Sale | $1,001 - $15,000 | Dec 30, 2013 | filing ↗ |
Most active DGX traders in Congress
EB
Earl Blumenauer
2 trades
DP
Dean Phillips
2 trades
RL
Richard L. Hanna
2 trades
Julia Letlow
Republican
1 trade
Carol Devine Miller
Republican
1 trade
KM
K. Michael Conaway
1 trade
Lois Frankel
Democrat
1 trade
Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.